BGN and cancer: In pancreatic cancer, biglycan is overexpressed, leading to the inhibition of TGF-β1-responsive and -unresponsive cancer cells through induction of G1-arrest, associated with an increase in p27 and reduction in cyclin A and proliferating cell nuclear antigen [113].